Introduction
Sensorineural hearing loss is one of the most common disorders in our society today, and although it is not a life-threatening impairment, it can have a substantial influence on the patient's day-to-day life. A common cause of this disorder is the degeneration of the sensory hair cells in the organ of Corti. Loss of these cells is irreversible in humans and other mammals, leading to permanent functional impairment, 1 and treatments of this impairment have limited efficacy.
Gene transfer is a powerful technique to introduce potentially therapeutic genes into target cells. Using this technique, future otological therapies may be able to prevent hair cell loss or replace missing hair cells, and consequently reduce functional impairment. Side effects and other technical obstacles still make gene transfer in the inner ear clinically unfeasible. To produce safe and practical applications of this technique, improvements in both viral vectors and delivery routes are necessary. Earlier studies on inner ear gene transfer have shown that the ear is a viable target for gene therapy. [2] [3] [4] [5] [6] The most efficient way to induce forced expression of transgenes in vivo is through viral mediated vectors, but the very nature of these vectors raises concerns about safety and potential side effects. In recent years, adenoassociated virus (AAV) has been found to have desirable characteristics such as low pathogenicity, high-infectious efficiency in non-dividing cells and sustained gene expression, which could make it one of the most effective viral vectors. [7] [8] [9] However, one of the disadvantages of this vector is that the effect of AAV gene therapy could be diminished in patients who possess AAV-neutralizing antibodies. AAV infection is common in humans and neutralizing antibodies against AAV-1, -2 and -3 are reported to be up-regulated in childhood. 10 To overcome this fundamental deficiency, investigation of other distinct AAV serotypes is necessary. One such vector is the bovine AAV (BAAV), which has been shown to be serologically distinct from AAV serotypes 1-4 11 and has been recently cloned and characterized. 12 Furthermore, limited inhibition by using pooled human immunoglobulins suggests minimal neutralizing antibody levels in the general human population. 12 In a recent study, BAAV showed significantly higher efficiency than AAV serotypes -2, -4 and -5 for transducing explants of rat inner ear epithelia in vitro. 13 Thus BAAV presents several attractive features that could overcome potential side effects and make the virus a new candidate for gene therapy.
In this study, we evaluated BAAV cell tropism and transduction efficiency in vivo, with b-actin-GFP as a reporter gene, in the inner ear of normal hearing and deafened guinea pigs. We evaluated both the efficiency of transduction and its side effects for two different routes of inoculation: the scala tympani (ST) and scala media (SM). ST inoculation is feasible for clinical application and is minimally invasive. SM inoculation, although not feasible clinically in human ears, may be of importance for investigating protein function by forced gene expression in the membranous labyrinth. We compared BAAV-mediated gene expression and side effects between normal hearing and deafened guinea pigs. Our data indicate that BAAV transduces the auditory epithelia with low pathogenicity, through both SM and ST injection, in both normal hearing and deaf models, suggesting that BAAV is a useful gene carrier for both therapeutic and basic inner ear research.
Results

Effects of inoculation on the auditory physiology of normal guinea pigs
To evaluate the effect of BAAV inoculation on the auditory physiology of normal hearing guinea pigs, we assessed the ABRs to clicks at 4, 12 and 20 kHz at three time points: before surgery, and 1 and 2 weeks after surgery. To separate the effects of injection route from the effects of BAAV activity, the same tests were carried out on animals receiving BAAV by each injection route (SM or ST). In addition, control groups were inoculated with 5 ml of artificial endolymph or perilymph through SM or ST, respectively, and were assessed by ABR audiometry at the same frequencies and time points as BAAV-treated animals. The contralateral ears (right ear) served as a second control.
Baseline thresholds were similar across all groups. At 1 week, the threshold shifts at all frequencies were significantly larger, indicating greater hearing loss in SM-inoculated animals ( Figure 1a and c) than in ST inoculated animals (Figure 1b and d) , irrespective of whether the animal received BAAV or the appropriate control serum (Po0.05). In all groups, the ABR thresholds seemed to improve slightly by week 2, but the differences between weeks were not significant. Threshold shifts in BAAV SM-and ST-inoculated animals were not significantly different from their respective control groups. The contralateral ears in all groups showed no change in thresholds across all time points and frequencies (data not shown).
Effect of BAAV SM and ST inoculation on histology of normal ears
We carried out SM or ST inoculation in normal guinea pigs with 5 ml of BAAV-b-actin-GFP and killed the animals 2 weeks after surgery. Whole mounts of the auditory sensory epithelium were stained to show distributions of GFP and F-actin by epi-fluorescence to evaluate the quantity and location of BAAV transgene expression. The distribution of GFP in the different cell types in each cochlear turn after BAAV inoculation into SM or ST is summarized in Table 1 .
Transgene expression of GFP in SM-inoculated animals was robust near the inoculation site (second turn), less prevalent in the basal turn and absent in the higher (third and fourth) turns. Transgene expression was abundant in the supporting cells in the area of inner and outer hair cells, and in Reissner's membrane (Figure 2a-d) . Among supporting cells, interdental, inner sulcus and Hensen cells were consistently transduced, but Deiters and pillar cells showed much less transgene expression. Hair cells were not transduced.
An important outcome of the SM inoculation was hair cell loss. The severity of the loss was substantial near the inoculation site, but it decreased further away from the site. 14 The contralateral (right) ears showed no transgene expression or pathological hair cell loss in any animals (data not shown).
In guinea pigs that received BAAV in ST, the gene expression was restricted to the vicinity of the inoculation site (basal turn). Cell types presenting gene expression in the basal turn epithelium were interdental, inner sulcus and Hensen cells, and rarely, outer hair cells (Figure 2e-h ). Outer hair cell transduction could only be Gene transfer in the guinea pig cochlea SB Shibata et al seen in the ST inoculation; however, pillar cells and Reissner's membrane, which were transduced through the SM route, were not affected through the ST route. Partial hair cell loss was also apparent in the basal turn of the ST-inoculated organ of Corti (Figure 2h ). In contrast, hair cell loss was not observed in the corresponding control group.
Effect of BAAV inoculation on the histology of deafened guinea pigs
Animals were deafened by a combination of subcutaneous kanamycin and intravenous ethacrynic acid; subsequently, hair cells degenerated and were replaced by scars. 15, 16 Three days later the deafened guinea pigs were inoculated with the same vector and concentration, by the same routes as normal guinea pigs and killed 2 weeks later. In order to assess the transduction of BAAV in deafened ears, we counted the number of ears with positive transgene expression, as in BAAV-inoculated normal guinea pigs (Table 1) .
In SM-injected deaf animals, GFP was seen in the second and basal turn, with strong transgene expression near the inoculation site (Figure 3a 
Discussion
This study characterizes the transgene expression of BAAV with b-actin-GFP injected into the inner ear normal hearing and deafened guinea pigs through two different routes: SM and ST inoculation. We show that in vivo inoculation through both routes transduces hair cells in normal guinea pigs and a variety of supporting cells in both normal and deafened guinea pigs, with minimal side effects.
BAAV effects on the auditory system
The ABR results from our control group showed significantly higher (worse) thresholds in the artificial endolymph-inoculated SM animals ( Figure 1c ) compared with the artificial perilymph inoculated ST animals ( Figure 1d ) at both 1 and 2 week time points. The elevated threshold in artificial endolymph-inoculated SM animals is thought to be the consequence of a mechanical disruption of the organ of Corti, possibly involving rupture of the Reissner's membrane and/or mixing of perilymph and endolymph fluids around the inoculation site. Thus, hair cell loss is most severe in this area and gradually diminishes away from the inoculation site, as described in earlier studies using this method in guinea pigs.
14 Animals inoculated with artificial perilymph into ST showed a threshold shift not more than 13 dB at the first week and 8 dB at the second week, which is also thought to be caused by the surgical procedure. ST inoculation caused little hair-cell loss in any cochlear turn; most of the damage was again near the site of injection. For both surgical approaches, the threshold shifts seen in BAAV-inoculated guinea pigs were comparable to those of the control animals ( Figure 1a and 1b), suggesting that injection of the BAAV had little or no side effects on auditory function. In addition, Table 1 The number of BAAV treated ears with positive b-actin-GFP transgene expression and the proportional range of positive cells in normal and deafened ears The presence and distribution of the transgene was assessed in the second and basal turn of SM inoculated guinea pigs and in the basal turn for ST inoculated guinea pigs. The transgene expression efficiency is higher after SM inoculation compared with the ST inoculation for both normal and deafened ears. The transgene expression is mainly observed in the supporting cells.
Values described in the 'Proportion of positive cells (%)' represent the ranges of positive cells among the GPs with GFP transgene expression.
Gene transfer in the guinea pig cochlea SB Shibata et al after the initial threshold shift, the ABR thresholds improved between the first and second week, supporting the inference that the functional effect of the procedure is because of the surgery, rather than the presence of the virus or the expression of the transgene. Together, these results indicate that BAAV has minimal detrimental effects on cell survival and function of the inoculated ears.
Distribution of transgene expression in normal guinea pigs
The distribution of transgene expression among cell types is shown in Table 1 . Transduction of Hensen, interdental and inner sulcus cells was shown in all groups receiving BAAV. The efficiency was high in the SM-inoculated guinea pigs, with almost all ears inoculated with BAAV showing transgene expression. The ST-inoculated guinea pigs typically did not show efficient gene expression, although a few outer hair cells did appear positive. The transgene efficiency was low in the ST-inoculated guinea pigs in both normal and deafened conditions. Therefore, these results suggest that cell types such as Hensen, interdental and inner sulcus can be transduced consistently by BAAV through both routes, but that transduction of hair cells and Reissner's membrane is dependent on the inoculation route. In addition, the proportion of transduced cells is much higher through the SM inoculation compared with the ST inoculation. Gene transfer in the guinea pig cochlea SB Shibata et al
In cultures of rat cochleae exposed to BAAV, an estimated 100% of Hensen cells; 40% of interdental and phalangeal cells; 10% of inner and outer hair cells; and 48% of vestibular cells were transduced. 13 The frequencies of Hensen, interdental and outer hair cell transduction are consistent with our data. In contrast, transduction of inner sulcus, Deiters cells, pillar cells and Reissner's membrane in the rat cultures was not observed. These discrepancies may be caused by differences in susceptibility to the effects of BAAV in the organ of Corti among species and by differences between culture and in vivo conditions.
Transfer of genes into hair cells is of importance for research issues such as understanding the function of gene products, and for clinical applications such as protection or phenotypic rescue for hereditary disease. However, work with adenovirus vectors in mature normal mammals has shown that the transduction was restricted to supporting cells. 14, 17, 18 The reasons for the lack of hair-cell transduction are not clear, especially considering that these cells do express the CAR receptor. 17, 18 As such, our current finding about BAAV transduction of hair cells is a positive first step toward work on protection and phenotypic rescue. However, means for increasing the efficiency of hair cell transduction need to be identified.
Different viral vectors seem to have different patterns of transduction in the cochlea. Inoculation with various serotypes of AAV (1, 2, 3, 5, 7, 8, and 9), into the murine or guinea pig cochlea in vivo, produced stronger transgene expression in the inner hair cells but weaker expression in the supporting cells. Inoculation with adenovirus showed robust transgene expression in the supporting cells when inoculated through the SM route 14 and in the mesothelial cells when inoculated through the ST route. 19 Therefore, the BAAV has similar transgene expression to that of adenovirus by way of showing high transduction efficiency in the supporting cells through the SM route and differs from other AAV serotypes by way of transducing mainly the supporting cells through the ST route.
The high transduction efficiency of supporting cells with BAAV through the SM route is an encouraging result for inducing transdifferentiation of supporting cells to hair cells, especially in research work. Such studies of regeneration are based on forced expression of genes that encode the hair cell phenotype during development, resulting in a phenotypic change of supporting cells. 20, 21 Our data suggest that BAAV would be an appropriate gene vector for SM inoculation leading to forced expression of Atoh1 and other genes that may induce regeneration in the organ of Corti. For clinical application, however, the SM approach is not feasible because of access limitation in the human ear. In contrast, the ST route is accessible, through the oval or round window. Our results on low-efficiency transduction of non-sensory cells through the ST constitute a proof for Gene transfer in the guinea pig cochlea SB Shibata et al the principle that BAAV can accomplish such transduction, but that higher efficiency will be needed for robust biological activity.
Distribution of transgene expression in deafened guinea pigs
The deafened animals exhibited scars that replaced missing hair cells. SM inoculation resulted in similar patterns of supporting cell transduction in normal and deafened animals. After ST inoculation, the pattern of supporting cell transduction was also comparable between deafened and normal animals. However, the staining intensity in the transduced cells of the deafened animals was lower and the efficiency of transduction was notably lower compared with normal guinea pigs. The reason for reduced transduction in traumatized ears as compared with normal ears is unclear. We speculate that the scarring process that follows hair cell loss leads to changes in supporting cells that reduce their affinity for transduction by BAAV after SM inoculation. Changes seen after ST inoculation could be caused by structural change (thickening) of the basilar membrane, as seen after amikacin treatment. 22 Similar thickening of the basilar membrane can be observed in presbycusis in humans. 23 This structural change of the basilar membrane may alter the permeability and allow less BAAV to reach the baso-lateral domains of membranous labyrinth cells. Changes of efficiency of virus uptake in the inner ear epithelium after induced lesions have been shown to occur, at times leading to increased efficiency. 24, 25 As the traumatized auditory epithelium will be the target for clinical reparative procedures, it is important to characterize the optimal vector designs, promoters and inoculation methods that would yield the desirable outcome in terms of efficiency and safety in deafened ears.
As the efficiency of transgene expression of BAAV is relatively low in deafened animals, practical application will require some means to enhance transgene expression. One important task is to elucidate the specific receptors for BAAV in the cochlea. Once receptors are identified, it would be possible to alter the virus construct for augmenting the affinity of these receptors, thereby leading to better transgene expression efficiency. Gangliosides have been reported to act as receptors for BAAV in vitro. 26 Therefore, co-inoculation of BAAV and gangliosides into the ST may enhance the transgene efficiency.
Pattern of GFP distribution within a cell
The intracellular distribution of the fusion b-actin-GFP protein was found to be present throughout the cytoplasm. This was expected given that G-actin is distributed throughout the cytoplasm. Over-expression of this fusion protein mediated by the BAAV is unregulated and as such excess gene product may even spread into the nucleus, but this was not observed in cochlear cells transduced with BAAV b-actin-GFP, showing that the cells were able to contain the protein in the cytoplasm.
Time course of gene expression
The BAAV showed transgene expression most efficiently 2 weeks after inoculation. This onset of gene expression is slower compared with that of adenovirus, which peaks several days after the inoculation, both in the ear 4 and in other tissues. 27 The delay in gene expression of BAAV is related to its molecular structure. BAAV is a singlestranded DNA virus; therefore, conversion into a doublestranded DNA in the nucleus is necessary for transgene expression. The late onset of gene expression makes this vector less desirable for goals related to rescue of cells after an insult has occurred. However, the long duration of gene expression (over several years) makes the vector attractive for long-term protective effects or for substitution of a mutated gene. 7 
Side effects of BAAV in the cochlea
In our in vivo study, it was possible to test the toxicity as well as the extent of immune response. We determined that the auditory system was largely preserved and the morphology of the middle ear was intact 2 weeks after the inoculation. All guinea pigs were healthy and had no signs of inflammation (discharge or contamination of fluids in the inner ear) 2 weeks after the surgery. Thus, no particular side effects from the BAAV were apparent in most of the animals. However, in ST-inoculated guinea pigs with BAAV, few hair cells were transduced and there was sporadic hair cell loss (Figure 2h) . This may suggest possible cytotoxicity of the virus. Hair cells may take up the virus and possibly degenerate. For adenovirus, the volume of 5 ml has been mentioned to be a safe volume with no apparent side effects. 28 However, the adenovirus injected into ST does not transduce cells of the membranous labyrinth, and so comparison of side effects on hair cells and hearing is difficult. It is likely that the volume of 5 ml may not be optimal for BAAV transduction. Modifying the virus volume or concentration of the BAAV may significantly reduce side effects.
BAAV delivery through SM and ST route
For future clinical intervention, the feasibility of inoculation surgery is a crucial factor. Owing to the difficulty in reaching the endolymphatic space of human temporal bone, SM inoculation is not readily adapted for humans, although other methods for reaching the endolymphatic space are plausible (for example, endolymphatic sac 29 ). An important outcome in this study was transduction of cells in the membranous labyrinth through ST inoculation, which is more feasible for clinical intervention. These data indicate that the BAAV may be a potential candidate for future clinical application, especially once means are found to enhance the efficiency of transgene expression in deafened animals.
Conclusions
We have shown that BAAV can shuttle genes into cells of the membranous labyrinth through endolymph or perilymph inoculation. Onset of gene expression is slow, but once expressed, it is sustained over a long time, with little or no side effects. Once efficiency can be increased, this vector has the potential for becoming useful for a wide range of applications for inner ear research and future clinical intervention.
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Materials and methods
Animals and groups
Animal care and handling were approved by the University of Michigan Institutional Committee on the Use of Care of Animals and were carried out using accepted veterinary standards. Twenty male pigmented guinea pigs weighing 300-350 g were purchased from Elm Hill, Chelmsford, MA, USA. Each animal was tested for normal Preyer's reflex before being included in the study. Normal hearing animals were divided into four groups, according to the inoculation site and injected reagent. One group of animals had BAAV ST inoculation (n ¼ 4). The second group had BAAV SM inoculation (n ¼ 4). The third group of animals had artificial perilymph (NaCl 145 mM, KCl 2.7 mM, MgSO 4 2.0 mM, CaCl 2 2H 2 O, HEPES, HPLC grade water and HPLC grade MeOH) ST inoculation (n ¼ 3). The last group had artificial endolymph (NaCl 1 mM, KCl 126 mM, KHCO 3 25 mM, MgCl 2 0.025 mM, CaCl 2 0.025 mM and K 2 HPO 4 1.4 mM) SM inoculation (n ¼ 3). Deafened animals were divided into two groups. One was inoculated in the ST with BAAV (n ¼ 3) and the other in the SM with BAAV (n ¼ 10). All cochleae in each group were processed for whole-mount (surface preparation) analysis.
Auditory brainstem response assessment
Auditory brainstem responses (ABRs) were assessed for each animal in both ears. The thresholds were measured by each ear for frequencies at 4, 12 and 20 kHz (tone bursts, 15 ms duration, 1 ms cos2-shaped rise-fall times) as described earlier. 30 ABRs were assessed before the inoculation surgery (baseline), 7 and 14 days after the inoculation surgery. We compared the threshold shift from baseline at 7 and 14 days. Furthermore, we compared the threshold shifts between the SM and ST inoculation for both BAAV and corresponding controls. Statistical analyses of ABR threshold shifts were carried out by ANOVA in SYSTAT. A P value o0.05 was considered statistically significant.
BAAV-b-actin-GFP vector construction, preparation and quantification
293T (human kidney) cells were maintained in Dulbecco's modified Eagle's medium supplemented with 10% fetal bovine serum. The media contained 2 mM L-glutamine, 100 U of penicillin ml -1 , and 0.1 mg of streptomycin ml -1 Cells were maintained at 37 1C under a 5% CO 2 humidified atmosphere. Recombinant BAAV expressing b-actin-GFP was produced using a fourplasmid procedure described earlier. 13 Briefly, semiconfluent 293T cells were transfected by calcium phosphate with four plasmids: an adenovirus helper plasmid (pAd12) containing the VA RNA, E2 and E4; two AAV helper plasmids containing the AAV2 Rep and BAAV Cap genes, respectively, and a vector plasmid containing AAV2 inverted terminal repeats flanking CMV-b-actin-GFP fusion expression cassette. The AAV2 vector plasmid containing the AAV2 inverted terminal repeats (ITRs) flanking the CMV-b-actin-GFP fusion expression cassette was constructed by subcloning the CMV promoter b-actin-GFP cassette from the b-actin-GFP plasmid (BD Biosciences, San Jose, CA, USA) into the AAV2 RSV-GFP expression plasmid and by replacement of the RSV-GFP cassette with the CMV b-actin-GFP. At 48 h posttransduction, the cells were harvested by scraping in TD buffer (140 mM NaCl, 5 mM KCl, 0.7 mM K2 HPO 4 , 25 mM Tris-HCl, pH 7.4) and the cell pellet was concentrated by low-speed centrifugation. Cells were lysed in TD buffer by three cycles of freeze-thaw. The clear lysate was treated with 0.5% deoxicolic acid and 100 U ml -1 DNase (Benzonase) for 30 min at 37 1C. Then the virus was purified using CsCl gradients. Particle titers were determined by QPCR. Amplification was detected using an ABI 7700 sequence detector (ABI). Specific primers for CMV were designed by using the Primer Express program (ABI): CMV forward 5 0 -CATC TACGTATTAGTCATCGCTATTACCAT-3 0 , CMV reverse 5 0 -TGGAAATCCCCGTGAGTCA-3 0 . After denaturation at 96 1C for 10 min, cycling conditions were 96 1C for 15 s, 60 1C for 1 min for 40 cycles. The viral DNA in each sample was quantified by comparing the fluorescence profiles with a set of DNA standards. The BAAV particle titers were in the range of 10 12 DNAse-resistant particles (DRP) ml -1 .
Inoculation and deafening surgeries
Under general anesthesia, the ST inoculation surgery was carried out as described earlier. 24 We inoculated the left ear with 5 ml BAAV and repeated the same procedure with artificial perilymph for the control group. SM inoculation surgery was carried out as described earlier, 14 except that we carried out cochleostomy in the second turn of the cochlea. We injected 5 ml of BAAV and repeated likewise with artificial endolymph for the control group.
For the deafening surgery, we used a single systemic dose of kanamycin (500 mg kg -1 , subcutaneously) followed by an intravenous injection of ethacrynic acid (50 mg kg -1 ) 31 . Deafness in each animal was verified by ABR 4 days after the surgery. Typically, animals showed a threshold shift of 80-90 db. We excluded any animal with a threshold shift less than this value after surgery. Excluded animals are not counted in the total number of animals reported here.
Immunohistochemistry
Fourteen days after the inoculation, animals had ABR assessment and were decapitated under general anesthesia. Both temporal bones were extracted and the cochleae were locally perfused with 4% paraformaldehyde (PFA). After 2 h of fixation with 4% PFA, the cochleae were rinsed in phosphate buffered saline (PBS).
The cochleae that were used for whole mounts in all groups were stained for reporter gene b-actin-GFP detection in both ears (including contralateral ear). Tissues were permeabilized with 0.3% Triton X-100 for 10 min, blocked against non-specific binding of secondary antibody by incubation in 5% normal donkey serum for 30 min. We incubated the tissues in mouse monoclonal antibody to GFP (Millipore (Chemicon), Billerica, MA, USA), diluted 1:200 in PBS, for 1 h. After rinsing with PBS twice, we used fluorescent-labeled donkey anti-mouse IgG Alexa Four 488 (Invitrogen, Molecular Probes, Eugene, OR, USA) as secondary antibodies diluted in 1:200 in PBS. We counterstained the tissue for F-actin with rhodamine-phallodin for 2 min diluted to 1:300 in PBS. After the tissues were washed with PBS, they were whole mounted on slides, cover-slipped with Gene transfer in the guinea pig cochlea SB Shibata et al
